Turkish Journal of Gastroenterology
Original Article

Laparoscopic distal pancreatectomy for benign or borderline malignant pancreatic tumors

1.

Department of Surgery, Soonchunhyang University Bucheon Hospital, Bucheon, Republic of Korea

Turk J Gastroenterol 2014; 25: 162-166
DOI: 10.5152/tjg.2014.4389
Read: 1120 Downloads: 370 Published: 25 July 2019

Abstract

Background/Aims: Laparoscopic distal pancreatectomy (LDP) for benign conditions is increasingly performed. But, there are few limited studies about the outcomes of the laparoscopic surgery compared with open surgery. The aim of this study was to evaluate the clinical outcomes of LDP and compare it to that of open distal pancreatectomy (ODP).

 

Materials and Methods: From July 2007 to February 2012, 60 consecutive patients (41 LDP patients and 19 ODP patients) who underwent elective distal pancreatectomy with an apparent diagnosis of benign or borderline malignant tumor were recruited into the current study.

 

Results: There were no significant differences in operation time, transfusion, intravenous patient-controlled analgesia (IV-PCA) duration, pancreatic fistula, mortality, and recurrence between the two groups. Compared to ODP, LDP had lower blood loss (272.7±134.8 vs. 476.9±140.8 ml; p=0.002), shorter time to first flatus (2.4±0.5 vs. 4.0±1.5 days; p=0.003), earlier time to oral intake (3.4±1.6 vs. 5.4±1.9 days; p=0.013), and shorter postoperative hospital stay (9.4±6.9 vs. 17.0±6.7 days; p=0.043).

 

 

Conclusion: LDP is a safe procedure and should be considered as a standard treatment option for benign or borderline malignant pancreatic tumors.

Files
EISSN 2148-5607